Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy

6 Pages

Summarizes Bayer’s ASPIREs project with IQVIA Technologies to automate site payments. Clinical trial sites often face delays and burdensome reconciliation; ASPIREs cut payment cycles by over 50%, reduced disputes by 77%, and eliminated end-of-trial reconciliation. The initiative increased transparency with real-time dashboards, improved site satisfaction, and freed staff from administrative tasks. Deployed in 18 countries, it demonstrates how automation enhances sponsor–site partnerships and accelerates study timelines.

Join for free to read

Case Study Clinical Trial Sponsor Uses Bioclinica Investigator Payments to…

White Paper Routes to Sponsor of Choice: From Shared Pipelines to…

White Paper Payments Modernization and Technology

Case Study Investigator Initiated Studies (IIS)

More from IQVIA

White Paper Routes to Sponsor of Choice: From Shared Pipelines to…

Vendor Sheet IQVIA Investigator Site Portal

Case Study Alnylam Puts Sites and Patients First with IQVIA Technologies…

Case Study Integration of IRT and eConsent with Unified Delivery Provides…

Case Study

Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy

Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy

You Might Also Like

More from IQVIA